Damien Keogh

Damien Keogh is the Chief Executive Officer, Director, and Founder at BluMaiden Biosciences, a biotechnology company focusing on human-first drug discovery within the human microbiome. Prior to this, Damien was the CEO and Co-Founder of Maiden Therapeutics and worked as a Venture Capital Entrepreneur In Residence at EVX Ventures. Damien also held roles as a Senior Research Fellow at Nanyang Technological University and as a Lecturer in Molecular Biology at Dublin City University. Damien holds a PhD in Molecular Biology from Dublin City University.